(19)
(11) EP 3 883 607 A2

(12)

(88) Date of publication A3:
02.07.2020

(43) Date of publication:
29.09.2021 Bulletin 2021/39

(21) Application number: 19887792.0

(22) Date of filing: 19.11.2019
(51) International Patent Classification (IPC): 
A61K 39/395(2006.01)
A61K 9/08(2006.01)
C07K 16/24(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 2039/505; C07K 16/244; A61K 45/06; A61K 2039/545; C07K 2317/76; C07K 2317/21; A61P 17/06
(86) International application number:
PCT/IB2019/059939
(87) International publication number:
WO 2020/104943 (28.05.2020 Gazette 2020/22)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 20.11.2018 US 201862769889 P
25.01.2019 US 201962796673 P
26.02.2019 US 201962810617 P
13.03.2019 US 201962817711 P
15.10.2019 US 201962915115 P

(71) Applicant: Janssen Biotech, Inc.
Horsham, PA 19044 (US)

(72) Inventors:
  • ANGSANA, Julianty
    San Diego, CA 92121 (US)
  • BRANIGAN, Patrick
    Spring House, PA 19477 (US)
  • DEPRIMO, Samuel
    San Diego, CA 92121 (US)
  • FLAVIN, Susan
    Spring House, PA 19477 (US)
  • LI, Shu
    Spring House, PA 19477 (US)
  • LIU, Xuejun
    San Diego, CA 92130 (US)
  • MUNOZ, Ernesto
    San Diego, CA 92121 (US)
  • RANDAZZO, Bruce
    Rydal, PA 19046 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) SAFE AND EFFECTIVE METHOD OF TREATING PSORIASIS WITH ANTI-IL-23 SPECIFIC ANTIBODY